Literature DB >> 36206462

Evaluating the Immunopathogenesis of Diabetes After Acute Pancreatitis in the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: From the Type 1 Diabetes in Acute Pancreatitis Consortium.

Anna Casu1, Paul J Grippo2, Clive Wasserfall3, Zhaoli Sun4, Peter S Linsley5, Jessica A Hamerman6, Brian T Fife7, Adam Lacy-Hulbert6, Frederico G S Toledo8, Phil A Hart9, Georgios I Papachristou9, Melena D Bellin, Dhiraj Yadav10, Maren R Laughlin11, Mark O Goodarzi12, Cate Speake13.   

Abstract

ABSTRACT: The association between acute pancreatitis (AP) and diabetes mellitus (DM) has long been established, with the initial descriptions of AP patients presenting with DM after a bout of AP published in the 1940s and 50s. However, the potential mechanisms involved, particularly those components related to the immune system, have not been well defined. The Diabetes RElated to Acute pancreatitis and its Mechanisms (DREAM) study is a multicenter clinical study designed to understand the frequency and phenotype of DM developing after AP. This article describes one objective of the DREAM study: to determine the immunologic mechanisms of DM after AP, including the contribution of β-cell autoimmunity. This component of the study will assess the presence of islet autoimmunity, as well as the magnitude and kinetics of the innate and adaptive immune response at enrollment and during longitudinal follow-up after 1 or more episodes of AP. Finally, DREAM will evaluate the relationship between immune features, DM development, and pancreatitis etiology and severity.
Copyright © 2022 Written work prepared by employees of the Federal Government as part of their official duties is, under the U.S. Copyright Act, a “work of the United States Government” for which copyright protection under Title 17 of the United States Code is not available. As such, copyright does not extend to the contributions of employees of the Federal Government.

Entities:  

Mesh:

Year:  2022        PMID: 36206462      PMCID: PMC9555855          DOI: 10.1097/MPA.0000000000002076

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.243


  60 in total

Review 1.  Understanding Human Autoimmunity and Autoinflammation Through Transcriptomics.

Authors:  Romain Banchereau; Alma-Martina Cepika; Jacques Banchereau; Virginia Pascual
Journal:  Annu Rev Immunol       Date:  2017-01-30       Impact factor: 28.527

2.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.

Authors:  G F Bottazzo; A Florin-Christensen; D Doniach
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

3.  GADA and anti-ZnT8 complicate the outcome of phenotypic type 2 diabetes of adults.

Authors:  Kadri Haller-Kikkatalo; Katrin Pruul; Kalle Kisand; Virge Nemvalts; Koit Reimand; Raivo Uibo
Journal:  Eur J Clin Invest       Date:  2015-02-14       Impact factor: 4.686

4.  Rationale and Design for the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: A Prospective Cohort Study From the Type 1 Diabetes in Acute Pancreatitis Consortium.

Authors:  Phil A Hart; Georgios I Papachristou; Walter G Park; Anne-Marie Dyer; Vernon M Chinchilli; Elham Afghani; Venkata S Akshintala; Dana K Andersen; James L Buxbaum; Darwin L Conwell; Kathleen M Dungan; Jeffrey J Easler; Evan L Fogel; Carla J Greenbaum; Rita R Kalyani; Murray Korc; Richard Kozarek; Maren R Laughlin; Peter J Lee; Jennifer L Maranki; Stephen J Pandol; Anna Evans Phillips; Jose Serrano; Vikesh K Singh; Cate Speake; Temel Tirkes; Frederico G S Toledo; Guru Trikudanathan; Santhi Swaroop Vege; Ming Wang; Cemal Yazici; Atif Zaheer; Christopher E Forsmark; Melena D Bellin; Dhiraj Yadav
Journal:  Pancreas       Date:  2022-07-01       Impact factor: 3.243

5.  Immunological findings in acute and chronic pancreatitis.

Authors:  Archana Bhatnagar; Jai Dev Wig; Siddartha Majumdar
Journal:  ANZ J Surg       Date:  2003 Jan-Feb       Impact factor: 1.872

6.  Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases.

Authors:  D U Rabin; S M Pleasic; J A Shapiro; H Yoo-Warren; J Oles; J M Hicks; D E Goldstein; P M Rae
Journal:  J Immunol       Date:  1994-03-15       Impact factor: 5.422

Review 7.  Advances in Type 1 Diabetes Prediction Using Islet Autoantibodies: Beyond a Simple Count.

Authors:  Michelle So; Cate Speake; Andrea K Steck; Markus Lundgren; Peter G Colman; Jerry P Palmer; Kevan C Herold; Carla J Greenbaum
Journal:  Endocr Rev       Date:  2021-09-28       Impact factor: 19.871

8.  Type 1 diabetes mellitus in patients with recurrent acute and chronic pancreatitis: A case series.

Authors:  Harmeet K Kharoud; Tetyana Mettler; Martin L Freeman; Guru Trikudanathan; Gregory J Beilman; Srinath Chinnakotla; Elissa Downs; Sarah J Schwarzenberg; Melena D Bellin
Journal:  Pancreatology       Date:  2020-12-06       Impact factor: 3.996

9.  The Relationship of Immune Cell Signatures to Patient Survival Varies within and between Tumor Types.

Authors:  Peter S Linsley; Damien Chaussabel; Cate Speake
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

10.  The Role of Mesenchymal Stem Cells with Ascorbic Acid and N-Acetylcysteine on TNF-α, IL 1β, and NF-κβ Expressions in Acute Pancreatitis in Albino Rats.

Authors:  Dalia Abdelhafez; Elshimaa Aboelkomsan; Abir El Sadik; Noha Lasheen; Sara Ashur; Amal Elshimy; George N B Morcos
Journal:  J Diabetes Res       Date:  2021-10-16       Impact factor: 4.011

View more
  3 in total

1.  Rationale and Design for the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: A Prospective Cohort Study From the Type 1 Diabetes in Acute Pancreatitis Consortium.

Authors:  Phil A Hart; Georgios I Papachristou; Walter G Park; Anne-Marie Dyer; Vernon M Chinchilli; Elham Afghani; Venkata S Akshintala; Dana K Andersen; James L Buxbaum; Darwin L Conwell; Kathleen M Dungan; Jeffrey J Easler; Evan L Fogel; Carla J Greenbaum; Rita R Kalyani; Murray Korc; Richard Kozarek; Maren R Laughlin; Peter J Lee; Jennifer L Maranki; Stephen J Pandol; Anna Evans Phillips; Jose Serrano; Vikesh K Singh; Cate Speake; Temel Tirkes; Frederico G S Toledo; Guru Trikudanathan; Santhi Swaroop Vege; Ming Wang; Cemal Yazici; Atif Zaheer; Christopher E Forsmark; Melena D Bellin; Dhiraj Yadav
Journal:  Pancreas       Date:  2022-07-01       Impact factor: 3.243

2.  Standard Operating Procedures for Biospecimen Collection, Processing, and Storage: From the Type 1 Diabetes in Acute Pancreatitis Consortium.

Authors:  Clive Wasserfall; Anne-Marie Dyer; Cate Speake; Dana K Andersen; Kendall Thomas Baab; Melena D Bellin; James R Broach; Martha Campbell-Thompson; Vernon M Chinchilli; Peter J Lee; Walter G Park; Richard E Pratley; Jami L Saloman; Emily K Sims; Gong Tang; Dhiraj Yadav; Cemal Yazici; Darwin L Conwell
Journal:  Pancreas       Date:  2022-07-01       Impact factor: 3.243

3.  Assessing the Pathophysiology of Hyperglycemia in the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: From the Type 1 Diabetes in Acute Pancreatitis Consortium.

Authors:  Kathleen M Dungan; Phil A Hart; Dana K Andersen; Marina Basina; Vernon M Chinchilli; Kirstie K Danielson; Carmella Evans-Molina; Mark O Goodarzi; Carla J Greenbaum; Rita R Kalyani; Maren R Laughlin; Ariana Pichardo-Lowden; Richard E Pratley; Jose Serrano; Emily K Sims; Cate Speake; Dhiraj Yadav; Melena D Bellin; Frederico G S Toledo
Journal:  Pancreas       Date:  2022-07-01       Impact factor: 3.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.